Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Moderna, Inc.(MRNA) | 2,308,190 | 2,308,190 | 0 | $68.07M | $117.26M | 33.56% | +$49.19M |
| Personalis, Inc.(PSNL) | 14,044,943 | 14,044,943 | 0 | $111.80M | $89.47M | 25.60% | -$22.33M |
| Kymera Therapeutics, Inc.(KYMR) | 772,165 | 772,165 | 0 | $60.08M | $64.31M | 18.40% | +$4.23M |
| Entrada Therapeutics, Inc.(TRDA) | 1,739,768 | 1,739,768 | 0 | $17.88M | $21.96M | 6.28% | +$4.07M |
| Eikon Therapeutics, Inc.(EIKN) | 0 | 1,666,666 | +1,666,666 | $0 | $17.63M | 5.05% | +$17.63M |
| Aktis Oncology, Inc.(AKTS) | 0 | 952,844 | +952,844 | $0 | $17.05M | 4.88% | +$17.05M |
| Alector Inc | 3,545,719 | 3,545,719 | 0 | $5.53M | $7.62M | 2.18% | +$2.09M |
| Sutro Biopharma, Inc.(STRO) | 272,351 | 272,351 | 0 | $3.15M | $6.78M | 1.94% | +$3.63M |
| Evaxion Biotech A/sADS | 1,214,126 | 1,214,126 | 0 | $5.79M | $4.52M | 1.29% | -$1.27M |
| Viridian Therapeutics, Inc.(VRDN) | 93,414 | 93,414 | 0 | $2.91M | $1.83M | 0.52% | -$1.08M |
| Xilio Therapeutics, Inc.(XLO) | 0 | 105,982 | +105,982 | $0 | $891.3K | 0.26% | +$891.3K |
| Carisma Therapeutics Inc | 1,473,240 | 1,473,240 | 0 | $63.3K | $47.9K | 0.01% | -$15.5K |
| Neuphoria Therapeutics Inc | 10,027 | 10,027 | 0 | $38.9K | $40.8K | 0.01% | +$1.9K |
| TuHURA Biosciences, Inc.(HURA) | 13,950 | 19,445 | +5,495 | $10.6K | $34.8K | 0.01% | +$24.3K |
| Xilio Therapeutics, Inc.(XLO) | 1,483,758 | 0 | -1,483,758 | $949.9K | $0 | — | -$949.9K |